FDA cleared oral decitabine/cedazuridine plus venetoclax for frontline AML in adults ≥75 years or with comorbidities that make intensive induction inappropriate. Study ASTX727-07 (single-arm, ...
Researchers at Moffitt Cancer Center are studying DYV800, a topical cream designed to reduce tumor acidity and help the ...
FDA accelerated approval covers relapsed/refractory MCL after ≥2 lines including a BTK inhibitor, positioning sonrotoclax as a potential first-in-class BCL-2 option in this setting. Single-arm ...
Dr. Susan MacDonald breaks down the TNM staging system (Tumor, Nodes, Metastasis) to help patients understand their clinical ...
Although the oncology community is buzzing with the potential of circulating tumor DNA (ctDNA) to revolutionize breast cancer ...
Pancreatic cancer remains one of the most difficult cancers to treat, with many patients facing a high risk of recurrence ...
Led by Dr. Moran Amit, MD Anderson is spearheading a pioneering clinical trial that combines the active ingredient found in so-called "magic mushrooms" with a rigorous psychotherapy framework. This ...
The second recipe, a turmeric latte, includes milk, turmeric, ginger, cinnamon, black pepper and honey. According to the ...
A rapid diagnostic-to-treatment interval and established clinician trust enabled decisive acceptance of an aggressive treatment plan, including systemic therapy, bilateral mastectomy with ...
Empathic acknowledgment of distress (“I’m sorry”) can rapidly establish therapeutic alliance and reduce isolating “Why me?” cognitions at diagnosis. Prognostic framing that is accurate and ...
Dr. Paul Oberstein discusses how personalized mRNA vaccines may improve long-term survival for patients with pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results